A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

248

Participants

Timeline

Start Date

July 22, 2020

Primary Completion Date

March 31, 2026

Study Completion Date

March 31, 2026

Conditions
Solid Neoplasms
Interventions
DRUG

Dazostinag

Dazostinag intravenous infusion.

DRUG

Pembrolizumab

Pembrolizumab intravenous infusion.

DRUG

Platinum

Carboplatin or Cisplatin intravenous infusion

DRUG

5-fluorouracil

5-fluorouracil intravenous infusion

Trial Locations (62)

1011

Centre Hospitalier Universitaire Vaudois Lausanne, Lausanne

1205

Hopitaux Universitaires de Geneve, Geneva

3010

Inselspital Universitatsspital Bern, Bern

4600

Klinikum Wels-Grieskirchen, Wels

9007

Kantonsspital Sankt Gallen, Sankt Gallen

13385

Hopital de la Timone, Marseille

15232

University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh

19111

Fox Chase Cancer Center, Philadelphia

21079

Centre Georges Francois Leclerc, Dijon

21201

University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore

25000

Centre Hospitalier Regional et Universitaire de Besancon - Hopital Jean-Minjoz, Besançon

32610

Memorial Cancer Institute at Memorial Hospital West - Cancer Institute/Radiology Oncology, Gainesville

33000

Hopital Saint-Andre, Bordeaux

37203

Sarah Cannon Research Institute (SCRI), Nashville

44805

Institut de Cancerologie de lOuest - Saint-Herblain - Site Rene Gauducheau, Saint-Herblain

45019

University of Cincinnati Health Barrett Cancer Center, Cincinnati

45069

West Chester Hospital, West Chester

48201

Barbara Ann Karmanos Cancer Institute - Lawrence and Idell Weisberg Cancer Treatment Center, Detroit

52621

The Chaim Sheba Medical Center, Tel Litwinsky

59000

Centre de Lutte contre le Cancer - Centre Oscar Lambret, Lille

60611

Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago

63031

Siteman Cancer Center - North County, Florissant

63129

Siteman Cancer Center - South County, St Louis

63141

Siteman Cancer Center - West County, Creve Coeur

63376

Siteman Cancer Center - St. Peters, City of Saint Peters

64239

Tel Aviv Sourasky Medical Center, Tel Aviv

69008

Centre Leon Berard, Lyon

75012

Hopital Saint-Antoine, Paris

75230

Mary Crowley Cancer Research, Dallas

92093

University of California San Diego Moores Cancer Center, La Jolla

92150

Hopital Foch, Suresnes

92868

UCI Health - Chao Family Comprehensive Cancer Center, Orange

94805

Gustave Roussy, Villejuif

97213

Providence Portland Medical Center, Portland

100142

Beijing Cancer Hospital, Beijing

200025

Fudan University Shanghai Cancer Center, Shanghai

200123

Shanghai East Hospital, Shanghai

310022

Zhejiang Cancer Hospital, Hangzhou

510655

Sixth Affiliated Hospital of Sun Yat-Sen University/Guangdong Gastrointestinal Hospital, Guangzhou

610041

West China Hospital, Chengdu

610610

West China School of Medicine - West China Hospital of Sichuan University, Chengdu

9112001

Hadassah University Hospital Ein Kerem, Jerusalem

9457108

Soroka Medical Center, Beersheba

90089-1019

Norris Comprehensive Cancer Center, Los Angeles

90404-2023

University of California Los Angeles - Jonsson Comprehensive Cancer Center, Santa Monica

80218-1238

SCRI - HealthOne Denver, Denver

06519

Yale Cancer Center, New Haven

02114

Massachusetts General Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

63110-1032

Washington University School of Medicine Siteman Cancer Center, St Louis

45219-2354

University of Cincinnati Health Barrett Cancer Center, Cincinnati

22031-2171

Virginia Cancer Specialists, P.C. - Fairfax, Fairfax

M5G 2M9

Princess Margaret Cancer Centre, Toronto

H3T 1E2

Jewish General Hospital, Montreal

H4A 3J1

McGill University Health Centre, Montreal

104-0045

National Cancer Center Hospital, Chuo-Ku

02-034

Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie - Panstwowy Instytut Badawczy, Warsaw

00936

PanOncology Trials: Universidad de Puerto Rico - Centro Comprensivo de Cancer, San Juan

BT9 7BL

Queen's University Belfast, Belfast

LS9 7TF

Leeds Teaching Hospitals NHS Trust, Leeds

NW1 2BU

University College London Hospitals NHS Foundation Trust, London

Ox1 2JD

Oxford University Hospitals NHS Foundation Trust, Oxford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY

NCT04420884 - A Study of Dazostinag as Single Agent and Dazostinag in Combination With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter